LifeMD, Inc. (LFMD)

NASDAQ: LFMD · Real-Time Price · USD
5.04
+0.14 (2.86%)
At close: Dec 20, 2024, 4:00 PM
5.18
+0.14 (2.78%)
After-hours: Dec 20, 2024, 6:33 PM EST
2.86%
Market Cap 218.29M
Revenue (ttm) 193.06M
Net Income (ttm) -25.61M
Shares Out 43.31M
EPS (ttm) -0.65
PE Ratio n/a
Forward PE 12.08
Dividend n/a
Ex-Dividend Date n/a
Volume 1,333,244
Open 4.88
Previous Close 4.90
Day's Range 4.76 - 5.15
52-Week Range 3.99 - 12.88
Beta 1.42
Analysts Strong Buy
Price Target 12.13 (+140.68%)
Earnings Date Nov 7, 2024

About LFMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair lo... [Read more]

Sector Healthcare
Founded 1994
Employees 211
Stock Exchange NASDAQ
Ticker Symbol LFMD
Full Company Profile

Financial Performance

In 2023, LifeMD's revenue was $152.55 million, an increase of 28.15% compared to the previous year's $119.03 million. Losses were -$23.70 million, -51.27% less than in 2022.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for LFMD stock is "Strong Buy." The 12-month stock price forecast is $12.13, which is an increase of 140.68% from the latest price.

Price Target
$12.13
(140.68% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Health care stocks jump on Trump's nominee for FDA head

CNBC's Angelica Peebles joins 'Fast Money' to talk president-elect Trump's pick for FDA head.

Other symbols: HIMSIBBMRNAPFE
25 days ago - CNBC Television

LifeMD, Inc. (LFMD) Q3 2024 Earnings Call Transcript

LifeMD, Inc. (NASDAQ:LFMD) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Justin Schreiber – Chairman and Chief Executive Officer Marc Benathen – Chief Financial Of...

6 weeks ago - Seeking Alpha

LifeMD Reports Third Quarter 2024 Results

Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65% Record gross margin of 90.6%, up 300 basis points from the year-ago period Adjusted EBITDA increased 33% to ...

6 weeks ago - GlobeNewsWire

LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividen...

3 months ago - GlobeNewsWire

LifeMD: Selling WorkSimpli Could Be A Catalyst

LifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value. Despite management's over-promising, LifeMD's telehealth and ...

3 months ago - Seeking Alpha

LifeMD to Participate in Three Investor Conferences During September

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following inv...

4 months ago - GlobeNewsWire

LifeMD, Inc. (LFMD) Q2 2024 Earnings Call Transcript

LifeMD, Inc. (NASDAQ:LFMD) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Justin Schreiber – Chairman and Chief Executive Officer Marc Benathen – Chief Financial Offi...

4 months ago - Seeking Alpha

LifeMD Reports Second Quarter 2024 Results

Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67% Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000 Weight...

4 months ago - GlobeNewsWire

LifeMD: High Growth GLP-1 Telehealth Play At A Discount

LifeMD is positioned as a high-growth telehealth play with a focus on GLP-1 weight management treatments. The company is guiding for 35% revenue growth in 2024. Its core telehealth business is expecte...

5 months ago - Seeking Alpha

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash di...

6 months ago - GlobeNewsWire

LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare

Identifying investment opportunities in the healthcare sector involves research on trends and next-gen tech. LifeMD offers telehealth services and weight management programs, positioned for growth in ...

6 months ago - Seeking Alpha

LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the Truist Securities H...

6 months ago - GlobeNewsWire

LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript

LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman & Chief Executive Officer Marc Benathen - Chief Financial Officer C...

8 months ago - Seeking Alpha

LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition

LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes LifeMD and Withings Health Solutions part...

8 months ago - GlobeNewsWire

LifeMD Appoints Dr. Calum MacRae to its Board of Directors

NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician...

8 months ago - GlobeNewsWire

LifeMD to Report First Quarter 2024 Financial Results on May 8

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ende...

8 months ago - GlobeNewsWire

LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 23rd Annual Needha...

9 months ago - GlobeNewsWire

LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program

LifeMD reported impressive revenue growth, with a 60% increase to $44.9 million, driven by a 90% increase in telehealth revenues. Weight management subscribers more than doubled sequentially, resultin...

10 months ago - Seeking Alpha

LifeMD, Inc. (LFMD) Q4 2023 Earnings Call Transcript

LifeMD, Inc. (NASDAQ:LFMD) Q4 2023 Earnings Conference Call March 11, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - CFO Conference Call Participants David L...

10 months ago - Seeking Alpha

LifeMD Reports Fourth Quarter 2023 Results

Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period. Adjusted EPS of $0.15 per share compared with $0.02 in the year...

10 months ago - GlobeNewsWire

LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the 11th Annual BTIG MedTech, Digital Health, ...

11 months ago - GlobeNewsWire

LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability

LifeMD, Inc.'s newly issued 2024 guidance indicates an impressive 38% CAGR, positioning it as an attractive investment opportunity. With a valuation priced at less than 11x forward EBITDA, LifeMD stoc...

11 months ago - Seeking Alpha

LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Con...

1 year ago - GlobeNewsWire

LifeMD: A GLP-1 Play With A Kicker

LifeMD expects a 38% increase in revenues for 2024, driven by its new telehealth operation for GLP-1 obesity drugs. Despite this, the stock is down significantly due to concerns over Eli Lilly direct ...

1 year ago - Seeking Alpha

LifeMD: Medifast Partnership Further Validates Weight Management Program

Medifast partners with LifeMD to offer virtual weight management program with access to GLP-1 drugs. Medifast invests $20 million in LifeMD, with $10 million represented by common stock purchase. Surv...

Other symbols: MED
1 year ago - Seeking Alpha